日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Sleep improvement in patients with rheumatoid arthritis treated with upadacitinib in real-world practice: results from the SLEERA study

在真实世界实践中，使用乌帕替尼治疗类风湿性关节炎患者的睡眠状况得到改善：SLEERA 研究的结果

期刊:Arthritis Research & Therapy
影响因子:4.6
doi:10.1186/s13075-026-03766-1
Hügle, Thomas; Prillwitz, Heino; Scholz, Godehard; Kyburz, Diego; Dudler, Jean; Schmiedeberg, Kristin; Zanisi, Laura; Harrer Kuster, Melanie D; Roulin, Pascal S; Rubbert-Roth, Andrea
关节炎
红斑狼疮
发表日期：2026
文献求助 收藏

Identification of individuals at high risk of developing rheumatoid arthritis: a balanced random forest model in a cohort of 1544 first-degree relatives

利用平衡随机森林模型识别患类风湿性关节炎高风险人群：一项针对1544名一级亲属的队列研究

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2025-005773
Aymon, Romain; Lamacchia, Céline; Gilbert, Benoit Thomas P; Grundhuber, Maresa; Gehring, Isabel; Swiniarski, Sascha; Studer, Olivia; Salis, Zubeyir; Guemara, Romain; Spoerl, David; Dudler, Jean; Möller, Burkhard; Dan, Diana; Brulhart, Laure; Von Mühlenen, Ines; Kyburz, Diego; Rubbert-Roth, Andrea; Ciurea, Adrian; Mueller, Ruediger; Courvoisier, Delphine S; Finckh, Axel
关节炎
发表日期：2025
文献求助 收藏

Anti-CD74 autoantibodies in axial spondyloarthritis as biomarkers for activity and severity of disease but not for tumour necrosis factor inhibitor retention: data from the Swiss Clinical Quality Management in rheumatic diseases cohort

抗CD74自身抗体在中轴型脊柱关节炎中可作为疾病活动度和严重程度的生物标志物，但不能作为肿瘤坏死因子抑制剂滞留的生物标志物：来自瑞士风湿病临床质量管理队列的数据

期刊:Clinical Rheumatology
影响因子:2.8
doi:10.1007/s10067-025-07393-0
Steimer, Annik; Götschi, Andrea; Witte, Torsten; Scherer, Almut; Brändli, Jonas; Nissen, Michael J; Möller, Burkhard; Grosswiler, Simon; Kyburz, Diego; Dan, Diana; Rubbert-Roth, Andrea; Adler, Sabine; Distler, Oliver; Baraliakos, Xenofon; Ciurea, Adrian
肿瘤
CD7
肿瘤免疫
CD74
关节炎
免疫/内分泌
发表日期：2025
文献求助 收藏

Efficacy and safety of upadacitinib in patients with rheumatoid arthritis and inadequate response or intolerance to biological treatments: results through 5 years from the SELECT-BEYOND study

SELECT-BEYOND 研究 5 年随访结果显示，对于生物制剂治疗反应不足或不耐受的类风湿性关节炎患者，upadacitinib 的疗效和安全性

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2023-003918
Fleischmann, Roy; Meerwein, Sebastian; Charles-Schoeman, Christina; Combe, Bernard; Hall, Stephen; Khan, Nasser; Carter, Kyle M; Camp, Heidi S; Rubbert-Roth, Andrea
关节炎
SELE
发表日期：2024
文献求助 收藏

Malignancy in the Upadacitinib Clinical Trials for Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis

在乌帕替尼治疗类风湿性关节炎、银屑病关节炎、强直性脊柱炎和非放射性中轴型脊柱关节炎的临床试验中发现恶性肿瘤

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-023-00621-6
Rubbert-Roth, Andrea; Kakehasi, Adriana M; Takeuchi, Tsutomu; Schmalzing, Marc; Palac, Hannah; Coombs, Derek; Liu, Jianzhong; Anyanwu, Samuel I; Lippe, Ralph; Curtis, Jeffrey R
肿瘤
肿瘤免疫
银屑病
关节炎
强直性脊柱炎
免疫/内分泌
发表日期：2024
文献求助 收藏

Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials

Upadacitinib治疗银屑病关节炎、强直性脊柱炎和非放射性中轴型脊柱关节炎长达5年的安全性：临床试验的综合分析

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00671-4
Burmester, Gerd R; Stigler, Jayne; Rubbert-Roth, Andrea; Tanaka, Yoshiya; Azevedo, Valderilio F; Coombs, Derek; Lagunes, Ivan; Lippe, Ralph; Wung, Peter; Gensler, Lianne S
强直性脊柱炎
关节炎
银屑病
免疫/内分泌
发表日期：2024
文献求助 收藏

Safety and Efficacy of Upadacitinib in Patients with Rheumatoid Arthritis Refractory to Biologic DMARDs: Results Through Week 216 from the SELECT-CHOICE Study

SELECT-CHOICE 研究中 Upadacitinib 对生物制剂 DMARD 难治性类风湿关节炎患者的安全性和有效性：截至第 216 周的结果

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-024-00694-x
Rubbert-Roth, Andrea; Kato, Koji; Haraoui, Boulos; Rischmueller, Maureen; Liu, Yanxi; Khan, Nasser; Camp, Heidi S; Xavier, Ricardo M
关节炎
SELE
发表日期：2024
文献求助 收藏

Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry

根据ASAS共识定义，早期中轴型脊柱关节炎：大型观察性注册研究中患者的特征及首个TNF抑制剂的疗效

期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2023-003455
Ciurea, Adrian; Götschi, Andrea; Bräm, René; Bürki, Kristina; Exer, Pascale; Andor, Michael; Nissen, Michael J; Möller, Burkhard; Hügle, Thomas; Rubbert-Roth, Andrea; Kyburz, Diego; Distler, Oliver; Scherer, Almut; Micheroli, Raphael
关节炎
发表日期：2023
文献求助 收藏

Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory Diseases

免疫介导性炎症疾病患者对 COVID-19 的易感性和疫苗接种后的免疫反应

期刊:Journal of Infectious Diseases
影响因子:4.5
doi:10.1093/infdis/jiad148
Finckh, Axel; Ciurea, Adrian; Raptis, Catherine E; Rubbert-Roth, Andrea
炎症/感染
炎症
免疫/内分泌
发表日期：2023
文献求助 收藏

Patient Disease Trajectories in Rheumatoid Arthritis Patients Treated with Baricitinib 4-mg in Four Phase 3 Clinical Studies

在四项 3 期临床研究中，接受 4 毫克巴瑞替尼治疗的类风湿性关节炎患者的疾病轨迹

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-022-00529-7
Taylor, Peter C; Chen, Yun-Fei; Pope, Janet; Weinblatt, Michael; Mysler, Eduardo; Rubbert-Roth, Andrea; Jia, Bochao; Sun, Luna; Liu, Yushi; Holzkämper, Thorsten; Tanaka, Yoshiya
关节炎
发表日期：2023
文献求助 收藏